Back to Search Start Over

Systemic therapy of necrobiotic xanthogranuloma: a systematic review

Authors :
Lisa Steinhelfer
Thomas Kühnel
Herbert Jägle
Stephanie Mayer
Sigrid Karrer
Frank Haubner
Stephan Schreml
Source :
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-9 (2022)
Publication Year :
2022
Publisher :
BMC, 2022.

Abstract

Abstract Background Even though a plethora of systemic therapies have been proposed for necrobiotic xanthogranuloma (NXG), there is no systematic review on this topic in literature. Objective To review all existing literature on the systemic therapy of NXG in order to identify the most effective therapies. Methods All reported papers in the literature were screened for systemic treatments of NXG. Papers without proper description of the therapies, papers describing topical therapy, and articles without assessment of effectiveness were excluded. Subsequently, we analyzed 79 papers and a total of 175 cases. Results The most effective treatments for NXG are intravenous immunoglobulins (IVIG), corticosteroids, and combination therapies including corticosteroids. Conclusions Corticosteroids and IVIG should therefore be considered first-line treatments in patients with NXG.

Details

Language :
English
ISSN :
17501172
Volume :
17
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Orphanet Journal of Rare Diseases
Publication Type :
Academic Journal
Accession number :
edsdoj.647b7d097e014f70aebedb0d081bbd5f
Document Type :
article
Full Text :
https://doi.org/10.1186/s13023-022-02291-z